Henry McKinnell

The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022.

The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY.

Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA.

Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.

EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Angiotech Pharmaceuticals (US), Inc. develops drugs for medicinal chemicals and botanical products. The company is located in North Bend, WA.

The New York City Police Foundation, Inc. operates as an independent, non-profit organization to promote excellence in the New York City Police Department. Its programs include counterrrorism, reward, neighborthood policing, inside the NYPD. The company was founded in 1971 and is headquartered in New York, NY.

The Economic Club of New York operates as a nonprofit, nonpartisan and nonpolitical organization. The company was founded by J.W. Beatson in 1907 and is headquartered in New York, NY.

ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.

The Business Council operates as an organization of business leaders. The company is headquartered in Washington, DC.

The Trilateral Commission operates a business policy-oriented forum.

The New York Public Library engages in the provision of library services. It uses its available resources in a program of collecting, cataloging, and conserving books and other materials, and providing ready access directly to individual library users and to users elsewhere through cooperating libraries and library networks. The company was founded in 1895 and is headquartered in New York, NY.

The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC.

The Royal Shakespeare Co. operates as a British live theatrical presentations company. The private company is based in Stratford-upon-Avon, UK and has subsidiaries in the United Kingdom. The company was founded by Peter Reginald Frederick Hall and the CEO is Michael Clasper.

Federal Street Acquisition Corp. operates as a blank check company which engages in the merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2017 and is headquartered in Boston, MA.

Business-Higher Education Forum is a non-profit membership organization that connects higher education institutions to business talent demand. The non-profit company is based in Washington. The American company helps corporate CEOs and university presidents to anticipate skills needs and improve pathways between higher education and workforce. The company identifies high-value emerging skills through yearly signature reports, ad hoc research, and timely quick takes. BHEF has a repeatable approach to accelerate pathway development between business and higher education, resulting in over 100 credentials.

Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned.